Henry Schein (HSIC) Stock Buyback History
TTM buyback yield 9.82% · Shareholder yield (TTM) 9.82%.
HSIC
TTM buyback yield
9.82%
Shareholder yield (TTM)
9.82%
5Y share count change
-15.1%
TTM buyback spend
$814.00M
SBC coverage (TTM)
30.15x
YoY change in spend
+120.8%
5Y CAGR of spend
+57.4%
Peak year (2025)
$850.00M
Cumulative spend
$6.03B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- Henry Schein (HSIC) repurchased about $814.00M of stock over the trailing twelve months.
- Diluted share count is down 15.1% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 30.15× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +57.4% per year over the latest 5-year window.
- TTM repurchases used about 189% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $850.00M | $0.00 | $850.00M | 0.12B | -4.7% | 9.51% |
| 2024 | $385.00M | $39.00M | $346.00M | 0.13B | -3.0% | 4.17% |
| 2023 | $284.00M | $39.00M | $245.00M | 0.13B | -4.4% | 2.89% |
| 2022 | $485.00M | $54.00M | $431.00M | 0.14B | -2.8% | 4.52% |
| 2021 | $401.00M | $78.00M | $323.00M | 0.14B | -1.1% | 3.74% |
| 2020 | $88.00M | $9.00M | $79.00M | 0.14B | -3.9% | 0.92% |
| 2019 | $525.00M | $44.92M | $480.08M | 0.15B | -2.9% | 5.41% |
| 2018 | $200.00M | $36.24M | $163.76M | 0.15B | -2.8% | 2.14% |
| 2017 | $450.00M | $42.29M | $407.71M | 0.16B | -2.6% | 5.18% |
| 2016 | $550.02M | $58.25M | $491.78M | 0.16B | -3.5% | 5.81% |
| 2015 | $299.85M | $44.61M | $255.24M | 0.17B | -1.9% | 2.94% |
| 2014 | $299.99M | $45.88M | $254.11M | 0.17B | -2.1% | 3.36% |
| 2013 | $300.25M | $35.53M | $264.72M | 0.18B | -2.5% | 3.94% |
| 2012 | $299.88M | $37.31M | $262.57M | 0.18B | -3.0% | 5.49% |
| 2011 | $200.00M | $42.73M | $157.27M | 0.19B | -0.7% | 4.46% |
| 2010 | $57.73M | $35.63M | $22.10M | 0.19B | 3.0% | 1.32% |
| 2009 | $0.00 | $31.23M | −$31.23M | 0.18B | -0.7% | — |
| 2008 | $82.79M | $25.43M | $57.36M | 0.18B | 0.1% | 3.24% |
| 2007 | $30.69M | $0.00 | $30.69M | 0.18B | 1.5% | 0.72% |
| 2006 | $40.26M | $19.46M | $20.80M | 0.18B | 1.5% | 1.19% |
| 2005 | $52.28M | $0.00 | $52.28M | 0.18B | -1.1% | 1.75% |
| 2004 | $82.21M | $0.00 | $82.21M | 0.18B | -0.3% | 3.46% |
| 2003 | $61.75M | $0.00 | $61.75M | 0.18B | 0.1% | 2.66% |
| 2002 | $0.00 | $0.00 | $0.00 | 0.18B | -48.5% | — |
| 2001 | $0.00 | $0.00 | $0.00 | 0.35B | 2.2% | — |
| 2000 | $0.00 | $0.00 | $0.00 | 0.34B | -72.8% | — |
| 1999 | $0.00 | $0.00 | $0.00 | 1.25B | 0.0% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 1.25B | 0.0% | — |
| 1997 | $600.00K | $0.00 | $600.00K | 1.25B | 0.0% | — |
| 1996 | $600.00K | $0.00 | $600.00K | 1.25B | — | — |
| 1995 | $3.00M | $0.00 | $3.00M | — | — | — |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for Henry Schein (HSIC) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for Henry Schein (HSIC)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for Henry Schein (HSIC)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $850.00M | +120.8% | +$465.00M | ||
| 2024 | $385.00M | +35.6% | +$101.00M | ||
| 2023 | $284.00M | -41.4% | -$201.00M | ||
| 2022 | $485.00M | +20.9% | +$84.00M | ||
| 2021 | $401.00M | +355.7% | +$313.00M | ||
| 2020 | $88.00M | -83.2% | -$437.00M | ||
| 2019 | $525.00M | +162.5% | +$325.00M | ||
| 2018 | $200.00M | -55.6% | -$250.00M | ||
| 2017 | $450.00M | -18.2% | -$100.02M | ||
| 2016 | $550.02M | +83.4% | +$250.17M | ||
| 2015 | $299.85M | -0.0% | -$137,000 | ||
| 2014 | $299.99M | -0.1% | -$262,000 | ||
| 2013 | $300.25M | +0.1% | +$368,000 | ||
| 2012 | $299.88M | +49.9% | +$99.88M | ||
| 2011 | $200.00M | +246.4% | +$142.27M | ||
| 2010 | $57.73M | — | +$57.73M | ||
| 2009 | $0 | -100.0% | -$82.79M | ||
| 2008 | $82.79M | +169.8% | +$52.10M | ||
| 2007 | $30.69M | -23.8% | -$9.57M | ||
| 2006 | $40.26M | -23.0% | -$12.01M | ||
| 2005 | $52.28M | -36.4% | -$29.94M | ||
| 2004 | $82.21M | +33.1% | +$20.46M | ||
| 2003 | $61.75M | — | +$61.75M | ||
| 2002 | $0 | — | $0 | ||
| 2001 | $0 | — | $0 | ||
| 2000 | $0 | — | $0 | ||
| 1999 | $0 | — | $0 | ||
| 1998 | $0 | -100.0% | -$600,000 | ||
| 1997 | $600,000 | 0.0% | $0 | ||
| 1996 | $600,000 | -80.0% | -$2.40M | ||
| 1995 | $3.00M | — | +$3.00M | ||
| 1994 | $0 | — | — |
Henry Schein (HSIC) most recent annual buyback spend stands at $850.00M (2025) – surged 120.8% year-over-year.
Henry Schein buyback spend has grown for 2 consecutive years, with a +57.4% compound annual growth rate over 2020–2025 (5 years).
$850.00M stands as the all-time-high annual buyback spend, posted in 2025, against a low of $0 during 1994.
Within Healthcare, Henry Schein (HSIC) ranks 7th among 8 peers we track. The peer median for buyback spend is $2.75B.
Henry Schein Buyback Spend 2025: $850.00M
Henry Schein buyback spend in 2025 was $850.00M, surged 120.8% from 2024. This figure represents the highest annual value in the available history.
Henry Schein Buyback Spend 2024: $385.00M
Henry Schein buyback spend in 2024 was $385.00M, surged 35.6% from 2023.
Henry Schein Buyback Spend 2023: $284.00M
Henry Schein buyback spend in 2023 was $284.00M, plunged 41.4% below 2022.
Henry Schein Buyback Spend 2022: $485.00M
Henry Schein buyback spend in 2022 was $485.00M, grew 20.9% from 2021.
Henry Schein Buyback Spend 2021: $401.00M
Henry Schein buyback spend in 2021 was $401.00M.
See more financial history for Henry Schein (HSIC).
Sector peers by buyback spend
Companies in the same sector as Henry Schein, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 30.15×.
Capital allocation mix
How Henry Schein splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $431.00M (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Henry Schein's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does Henry Schein buy back its own stock?
Yes, Henry Schein (HSIC) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Henry Schein spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $814.00M (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Henry Schein's buyback yield?
TTM buyback yield is about 9.82% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Henry Schein's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 9.82% combined (TTM-based where available).
Is Henry Schein diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Henry Schein's share count changed?
Diluted weighted average shares changed by about -15.1% over roughly five fiscal years (annual income statement data).
What is Henry Schein's buyback spend?
Latest reported buyback spend for Henry Schein (HSIC) is $814.00M (period ending March 28, 2026).
How has Henry Schein buyback spend changed year-over-year?
Henry Schein (HSIC) buyback spend changed +120.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Henry Schein buyback spend?
Henry Schein (HSIC) buyback spend compound annual growth rate is +57.4% over the most recent 5 years available.
When did Henry Schein buyback spend hit its highest annual value?
Henry Schein buyback spend reached its highest annual value of $850.00M in 2025.
What was Henry Schein buyback spend in 2024?
Henry Schein (HSIC) buyback spend in 2024 was $385.00M.
What was Henry Schein buyback spend in 2025?
Henry Schein (HSIC) buyback spend in 2025 was $850.00M.
Explore more
HSIC Overview
Company profile, financial tools, and key metrics
HSIC Revenue Counter
Earns $424.40 every second. See per minute, hour, and day.
HSIC Earnings Counter
Earns $12.53 per second net profit. See per minute, hour, and day.
HSIC Economic Scale
Exceeds Namibia's GDP. Compare with world economies.
HSIC What If Invested
What if you had invested $1,000? See historical returns from any date.
HSIC How It Makes Money
Discover visual breakdown of $13.38B in revenue — where it comes from and where it goes.
HSIC Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
HSIC Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
HSIC Daily Price Character
Balanced · 50.2% historical win rate (green days). Streaks & record days.
HSIC Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
HSIC Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.